Anti-oncogenic and immunological functions of ATP23 in CMS4 colon adenocarcinoma based on a machine learning computational framework
PeerJ · 2026
DOI: 10.7717/peerj.20838 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2026. Verfasst von Yafei Yin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Second Qilu Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Adenocarcinoma, Colonic Neoplasms, Mitochondrial Proton-Translocating ATPases. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clinical Science and Technology Innovation Program of Jinan Science and Technology Project, Shandong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Background
Consensus Molecular Subtype (CMS) 4 and BRAF mutations are poor prognostic indicators for colon adenocarcinoma (COAD). Although the prevalence of BRAF-mutated COAD is higher in the CMS1 subtype, we have identified certain cases of CMS4 subtypes in patients with BRAF mutations. However, there is currently a lack of research exploring whether this particular type of COAD exhibits a worse prognosis and unraveling its underlying mechanism.
Methods
This retrospective study analyzed the transcriptome profiles and clinical parameters of COAD patients from six public datasets. Kaplan–Meier plots and bioinformatics methods predicted the correlation between ATP23 expression and patient survival. We compared enriched pathways, genomic mutations, immune cell infiltration, copy number alterations, cell–cell communication, and TIDE scores between ATP23-high and ATP23-low groups. Furthermore, in vitro experiments verified the potential roles of ATP23 in COAD.
Results
The expression of ATP23 was significantly lower in tumor tissues, particularly in the CMS4 subtype. No significant correlation was observed between ATP23 expression and clinical characteristics or molecular mutations in COAD. Higher ATP23 levels were associated with improved survival rates in COAD patients. In vitro experiments indicated that ATP23 inhibits the proliferation, migration, and invasion capabilities of COAD cells. Moreover, decreased ATP23 expression may impair oxidative phosphorylation in T cells, contributing to the formation of an immune-evasive microenvironment, and potentially leading to reduced efficacy of both immunotherapy and conventional chemotherapy.
Conclusions
ATP23 is a potential prognostic marker for COAD patients. Reduced ATP23 expression may inhibit oxidative phosphorylation in T cells and contribute to the formation of an immunosuppressive microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Second Qilu Hospital of Shandong University, Jinan, China.
- Department of Gastroenterology, Dongying District People's Hospital, Dongying, China.
- Department of Gastrointestinal Endoscopy Center, The Second Qilu Hospital of Shandong University, Jinan, China.
Förderung
- Clinical Science and Technology Innovation Program of Jinan Science and Technology Project
- Shandong Provincial Natural Science Foundation
Zitieren
APA
Yin, Y., Zhang, H., Li, S., Gu, R., Wang, J., Zhang, Z., & Sun, J. (2026). Anti-oncogenic and immunological functions of ATP23 in CMS4 colon adenocarcinoma based on a machine learning computational framework. PeerJ. https://doi.org/10.7717/peerj.20838
Vancouver
Yin Y, Zhang H, Li S, Gu R, Wang J, Zhang Z, et al. Anti-oncogenic and immunological functions of ATP23 in CMS4 colon adenocarcinoma based on a machine learning computational framework. PeerJ. 2026. doi:10.7717/peerj.20838
BibTeX
@article{Yin2026,
author = {Yin, Yafei and Zhang, Huimin and Li, Shuai and Gu, Ruru and Wang, Jian and Zhang, Zhen and Sun, Juntao},
title = {Anti-oncogenic and immunological functions of ATP23 in CMS4 colon adenocarcinoma based on a machine learning computational framework},
journal = {PeerJ},
year = {2026},
doi = {10.7717/peerj.20838}
}
EUVIMED